Sun Pharmaceutical fixes record date for ₹5 final dividend
Sun Pharmaceutical Industries Ltd has fixed July 7, 2026, as the record date for a final dividend of ₹5 per share for FY 2025-26. The dividend payment is scheduled for on or before August 7, 2026, subject to shareholder approval at the 34th AGM on July 31, 2026. Shareholders must submit TDS documents by July 7, 2026.
*this image is generated using AI for illustrative purposes only.
Sun Pharmaceutical Industries Ltd has fixed Tuesday, 07 July 2026, as the record date to determine shareholder eligibility for a final dividend of ₹5 per equity share for the financial year 2025-26. The payment of this dividend, if approved by shareholders, will be made on or before Friday, 07 August 2026. The dividend distribution is subject to tax deduction at source (TDS) at applicable rates, with shareholders required to submit necessary documents by the record date to ensure the correct TDS rate is applied.
The company announced that its 34th Annual General Meeting (AGM) will be held on Friday, 31 July 2026, at 4:00 p.m. IST via Video Conferencing. The Notice convening the AGM and the Annual Report for FY 2025-26 will be dispatched to shareholders in compliance with statutory requirements. Shareholders have been advised to update their contact details with their Depository Participants or the company's Registrar and Transfer Agent to ensure timely delivery of documents and dividend credits.
Key AGM and Dividend Details
| Event | Date | Details |
|---|---|---|
| Record Date | 07 July 2026 | For determining entitlement to the final dividend |
| Final Dividend | ₹5 per share | For the financial year 2025-26 |
| AGM Date | 31 July 2026 | 34th Annual General Meeting via Video Conferencing |
| Dividend Payment | On or before 07 August 2026 | Subject to shareholder approval |
| TDS Document Submission | 07 July 2026 | Deadline for submitting documents for appropriate TDS |
The company has provided guidance on TDS and the document submission process via its official website and a QR code. Anoop Deshpande, Company Secretary and Compliance Officer, signed the intimation on 11 June 2026.
Historical Stock Returns for Sun Pharmaceutical
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.75% | +1.55% | -3.47% | +0.03% | +6.93% | +165.33% |
How will the final dividend payout impact Sun Pharma's free cash flow and capital allocation plans for FY 2026-27?
What strategic initiatives or growth targets are likely to be highlighted during the 34th AGM regarding the company's global expansion?
Could the dividend announcement signal a shift in Sun Pharma's policy towards higher shareholder returns in the coming years?
18
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
